Lanean...
Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease
OBJECTIVE: Heparanase (HPA), mammalian endo-β-D-glucuronidase, separates heparan sulfate chains of proteoglycans and changes the structure of the extracellular matrix. We investigated whether serum levels of HPA differ in patients with stable coronary artery disease (SCAD) and subjects with normal...
Gorde:
| Argitaratua izan da: | Med Princ Pract |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
S. Karger AG
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6944950/ https://ncbi.nlm.nih.gov/pubmed/31480068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503085 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|